KARA SAGGIOMO: Open Payments
NPI 1770668956 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$27,775 in 73 payments from 18 companies in 2025. Trend: 2023 $25,127 · 2024 $20,197 · 2025 $27,775
Speaker / faculty: $17,475Consulting: $5,935Travel & lodging: $2,645Food & beverage: $1,621Education: $100
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 38 | $19,610 |
| E.R. Squibb & Sons, L.L.C. | 3 | $5,060 |
| AstraZeneca Pharmaceuticals LP | 9 | $2,682 |
| ABBVIE INC. | 4 | $64 |
| Genentech USA, Inc. | 3 | $52 |
| Daiichi Sankyo Inc. | 2 | $42 |
| PFIZER INC. | 1 | $35 |
| Astellas Pharma US Inc | 2 | $34 |
| GENZYME CORPORATION | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
Products named: Jakafi, CALQUENCE, Niktimvo, Vanflyta, Xospata, SARCLISA, VENCLEXTA, Fabhalta.
Industry payments across NJ — which companies pay providers there.
